Nova Mentis Life Science
在场
健康
Nova Mentis Life Science 拥有 1,982 家竞争者，其中包括 UnitedHealth Group (美国(美洲))、UnitedHealthcare (美国(美洲)) 和 Siemens Healthineers (德国)。
Popular M&A news in 健康
- Oura Health 刚刚宣布为 200 筹款数百万美元。 (公布2024十二月20号).
- Neuronetics 已收购 Greenbrook TMS (公布2024十二月10号).
- Cleerly 刚刚宣布为 106 筹款数百万美元。 (公布2024十二月9号).
健康 行业的其他推荐联系人
消息
Nova Mentis Life Science 的最新新闻稿
- Nova Mentis Assigns Intellectual Property
- Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
- Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
- Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
- Nova Mentis to Enter mRNA AI Diagnostics Business
- Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial
- Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
- Nova Mentis Provides Corporate Update and 2023 Outlook
- Nova Mentis Appoints Derek Ivany as Executive Chairman
- Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial
- View more press releases Close
通过电子邮件
